ACA Medicaid Expansions Didn't Increase States' Spending

This article originally appeared here.
Share this content:
ACA Medicaid Expansions Didn't Increase States' Spending
ACA Medicaid Expansions Didn't Increase States' Spending

TUESDAY, April 18, 2017 (HealthDay News) -- Federal funding insulated state budgets from increased spending related to Medicaid expansion, according to a study published in the April issue of Health Affairs.

Benjamin D. Sommers, M.D., Ph.D., from Harvard University, and Jonathan Gruber, Ph.D., from the Massachusetts Institute of Technology, both in Boston, used data from the National Association of State Budget Officers (fiscal years 2010 to 2015) and a difference-in-differences framework to assess the effects of the Medicaid expansion's first two fiscal years.

The researchers found that expansion led to an 11.7 percent increase in overall spending on Medicaid, which was accompanied by a 12.2 percent increase in spending from federal funds. State funds did not experience significant increases in spending as a result of the expansion. Nor did states significantly reduce spending on education or other programs as a result of Medicaid expansion.

"States' advance budget projections were also reasonably accurate in the aggregate, with no significant differences between the projected levels of federal, state, and Medicaid spending and the actual expenses as measured at the end of the fiscal year," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths